MDedge Cardiocast is the weekly news podcast from Cardiology News hosted by interventional cardiologist Jim Dwyer, MD. Subscribe now.
Dec 27, 2019
ISCHEMIA trial hailed as practice changing
The largest-ever RCT of initial invasive versus conservative
management of stable ischemic heart disease makes waves.
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in
nondiabetics
Further analyses from the DAPA-HF trial showed dapagliflozin cut
death and heart failure...
Dec 20, 2019
Vascepa approved for cardiovascular risk
reduction
The FDA’s decision on cutting events in high-risk patients was
based primarily on the REDUCE-IT trial.
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV
death, bleeding
Novel oral anticoagulants may be preferred over warfarin in
patients with diabetes...
Dec 13, 2019
Women have fewer cardiovascular events after non–ST-segment
elevation ACS
But they also remain undertreated with guideline-directed
therapies.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
Dec 6, 2019
Icosapent ethyl cost effective in REDUCE-IT
analysis
Treatment with the fish-derived drug Vascepa for
CV event reduction is more effective and less costly than
placebo.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
Nov 29, 2019
This week’s Cardiocast is devoted entirely to Card Talk with cardiologist brothers Jim and Jerry Dwyer. They welcome two structural interventionalists at the Structural Heart and Valve Center at Emory Healthcare, Kendra J. Grubb, MD, and Isida Byku, MD. Both followed a unique track, training in both cardiac surgery...